BORREGAARD Aktie

 

Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025....

Tom Erik Foss-Jacobsen assumed his position as Borregaard's new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025)....

Borregaard's operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and BioMaterials increased while Fine Chemicals had a lower result. Continued growth in sales to agriculture was the main reason for the improved result in BioSolutions. In BioMaterials, the result increased due to higher sales prices, improved product mix and increased sales volume, partly offset by higher wood costs. Lower sales prices for bioethanol were the main reason for the weaker result in Fine Chemicals. The net currency effects were positive in all areas....

9 July 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG)...

Borregaard ASA has issued a commercial paper ISIN NO0013597476 of NOK 100,000,000....

Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August (see stock exchange release dated 23 May 2025)....

John Arne Ulvan, member of the board of Borregaard ASA, has on 27 May 2025 purchased 2,000 shares in Borregaard ASA at a price of NOK 188.04 per share. Following this transaction, John Arne Ulvan owns 5,500 shares in Borregaard ASA. The shares are purchased at Oslo Stock Exchange....

Tom Erik Foss-Jacobsen has been appointed CEO of Borregaard ASA. He succeeds Per A. Sørlie, who will retire after 26 years in the position (see notice to Oslo Stock Exchange 3 December 2020). The appointment will be effective 1 August 2025....

Borregaard's operating revenues increased to NOK 2,036 million (NOK 1,975 million)2 in the 1st quarter of 2025. EBITDA1 reached NOK 511 million (NOK 442 million). The result in BioSolutions increased, BioMaterials had a result in line with the corresponding quarter last year and Fine Chemicals had a lower result....

23 April 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG)...

The shares in Borregaard ASA will be traded ex-dividend of NOK 4.25 per share as from today, 11 April 2025....

Das Instrument BO4 NO0010657505 BORREGAARD ASA EQUITY wird ex Dividende/Zinsen gehandelt am 11.04.2025 The instrument BO4 NO0010657505 BORREGAARD ASA EQUITY has its ex-dividend/interest day on 11.04.2025...

Borregaard ASA has issued a commercial paper ISIN NO0013536136 of NOK 200,000,000....

10 April 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG)...

Das Instrument BO4 NO0010657505 BORREGAARD ASA EQUITY wird cum Dividende/Zinsen gehandelt am 10.04.2025 und ex Dividende/Zinsen am 11.04.2025 The instrument BO4 NO0010657505 BORREGAARD ASA EQUITY has its pre-dividend/interest day on 10.04.2025 and its ex-dividend/interest day on 11.04.2025...

Scope Ratings GmbH has affirmed Borregaard ASA's issuer rating of A-/Stable. The same rating is assigned to the company's senior unsecured debt....

In connection with Borregaard's Annual General Meeting, Mr. Helge Aasen, Chair of the Board of Directors in Borregaard ASA, has been assigned voting rights based on proxies for 7,137,969 shares in Borregaard ASA. The proxies apply exclusively to the Annual General Meeting in Borregaard ASA on 10 April 2025. This means that Mr. Helge Aasen represents a total of 7,14 % of the outstanding shares in Borregaard ASA....

The Annual General Meeting of Borregaard ASA will be held on 10 April 2025 at 13:00 CEST as a digital meeting....

Borregaard's Annual Report for 2024 is published today....

Borregaard ASA has issued a commercial paper ISIN NO0013511808 of NOK 100,000,000....